Triparatide lipoacylated derivative

The invention provides a teriparatide analogue. According to the analogue, modification and/or amino acid substitution are carried out on the site 13, the site 16, the site 26, the site 27 and/or the site 33 of the N end of teriparatide. The teriparatide analogue disclosed by the invention has the c...

Full description

Saved in:
Bibliographic Details
Main Authors ZHANG XIQUAN, FENG JUN, LU WEIGEN, DONG YUANZHEN, RUAN SIDA
Format Patent
LanguageChinese
English
Published 27.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides a teriparatide analogue. According to the analogue, modification and/or amino acid substitution are carried out on the site 13, the site 16, the site 26, the site 27 and/or the site 33 of the N end of teriparatide. The teriparatide analogue disclosed by the invention has the capability of transcellular transport mediated by a cholic acid transporter, and the cell infiltration capability and the stability in gastrointestinal digestive enzymes are obviously improved compared with those of teriparatide. 本发明提供一类特立帕肽类似物,所述类似物是在特立帕肽N端的13位、16位、26位、27位和/或33位发生修饰和/或氨基酸替换。本发明的特立帕肽类似物,具有胆酸转运体介导的跨细胞转运的能力,细胞渗透能力及在胃肠道消化酶中的稳定性较特立帕肽有了明显的升高。
AbstractList The invention provides a teriparatide analogue. According to the analogue, modification and/or amino acid substitution are carried out on the site 13, the site 16, the site 26, the site 27 and/or the site 33 of the N end of teriparatide. The teriparatide analogue disclosed by the invention has the capability of transcellular transport mediated by a cholic acid transporter, and the cell infiltration capability and the stability in gastrointestinal digestive enzymes are obviously improved compared with those of teriparatide. 本发明提供一类特立帕肽类似物,所述类似物是在特立帕肽N端的13位、16位、26位、27位和/或33位发生修饰和/或氨基酸替换。本发明的特立帕肽类似物,具有胆酸转运体介导的跨细胞转运的能力,细胞渗透能力及在胃肠道消化酶中的稳定性较特立帕肽有了明显的升高。
Author ZHANG XIQUAN
DONG YUANZHEN
FENG JUN
RUAN SIDA
LU WEIGEN
Author_xml – fullname: ZHANG XIQUAN
– fullname: FENG JUN
– fullname: LU WEIGEN
– fullname: DONG YUANZHEN
– fullname: RUAN SIDA
BookMark eNrjYmDJy89L5WRQDinKLEgsSizJTElVyMksyE9MrsxJLElNUUhJLcosA4qXpfIwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknhnP0NDM2NjYwNLI0djYtQAAPjJKKc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 特立帕肽脂酰化衍生物
ExternalDocumentID CN116333092A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN116333092A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:01:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN116333092A3
Notes Application Number: CN202211615599
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230627&DB=EPODOC&CC=CN&NR=116333092A
ParticipantIDs epo_espacenet_CN116333092A
PublicationCentury 2000
PublicationDate 20230627
PublicationDateYYYYMMDD 2023-06-27
PublicationDate_xml – month: 06
  year: 2023
  text: 20230627
  day: 27
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
SHANGHAI DUOMIRUI BIOTECHNOLOGY CO., LTD
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
RelatedCompanies_xml – name: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
– name: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
– name: SHANGHAI DUOMIRUI BIOTECHNOLOGY CO., LTD
Score 3.611762
Snippet The invention provides a teriparatide analogue. According to the analogue, modification and/or amino acid substitution are carried out on the site 13, the site...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Triparatide lipoacylated derivative
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230627&DB=EPODOC&locale=&CC=CN&NR=116333092A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUhLSks2sQTmtDSDRF0TU3Nz3SQz0zRgvkpLNUsFVrHJieAFsn5mHqEmXhGmEUwMWbC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2jsGtaeNzNVcnGxdA_xd_J3VnJ1tnf3U_IJsDYHtDmDX3dLIkZmBFdSMBp2z7xrmBNqVUoBcpbgJMrAFAE3LKxFiYKrKEGbgdIbdvCbMwOELnfAGMqF5r1iEQTkEmL_BB3WnpCrkZBbkJyZX5gCNSFFIAaaiMvAB3qIMim6uIc4eukDb4uFei3f2QzjMWIyBBdjlT5VgULBMNUwzNjQzS0ozSzJJTklKNDYGdmOTzFISk0ws0gyTJRmkcJsjhU9SmoELFEygxU5G5jIMLCVFpamywGq1JEkOHB4APM98jA
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkXnV0XpW9F-petDEZeuVN26IVX2Npq0wclwxVVF_3qvoXO-6FtI4JIc-eXyS-4uAOdtwQS3XESauEw0y3YcjRFbIK5ERjI0sTyRDrIRCR-s25E9qsHzIhZG5gn9kMkREVEc8V7I_TpfXmL50rdyfsEmWDW7CmLPVyt2XJ6nDUf1O153OPAHVKXUo5Ea3Xs6njuQurvG9QqsOkgJJVV67JRRKflvkxJswtoQpb0UW1D7empCgy5-XmvCer968MZihb35NpzFiG-ZqDvNlOkknyX8c4oiUiXFVfQuE3jvwGnQjWmoYW_jn6mNabQcmLkLdaT82R4obqYLUyeECcIsnrLENJHGMpImzGoLne9D6285rf8aT6ARxv3euHcT3R3ARqmy0vHJcA6hXry-ZUdoYgt2LHXzDTRNf3Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Triparatide+lipoacylated+derivative&rft.inventor=ZHANG+XIQUAN&rft.inventor=FENG+JUN&rft.inventor=LU+WEIGEN&rft.inventor=DONG+YUANZHEN&rft.inventor=RUAN+SIDA&rft.date=2023-06-27&rft.externalDBID=A&rft.externalDocID=CN116333092A